Genetic Mutations at BIOMEX
Unlock the Next Breakthrough in Cancer Therapy with Genetic Mutations at BIOMEX, we are leading the way in precision medicine, leveraging advanced genetic testing to drive the discovery and development of tailored therapies. Our repository, comprising over 3,000,000 FFPE blocks, coupled with our validated mass spectrometry-based system, enables faster detection of up to 96 mutations […]
BIOMEX at ADLM 2024
The past three days at ADLM2024 in Chicago have been incredibly exciting for the BIOMEX team! Thank you to everyone who visited our booth at ADLM 2024! We had the opportunity to network with industry leaders and present our latest studies, such as our HIV lay study and the lay study on the approval of […]
Businessbike as a new benefit for employees
Would you prefer to work for a company that prioritizes work-life balance? We at BIOMEX like to introduce Businessbike as a new employee benefit! We believe in fostering a supportive work environment that promotes both health and sustainability. Choosing a business bike is about more than just commuting to work – it’s about promoting personal […]
Our Human Tissue Bank
Imagine the breakthroughs you could achieve with access to Europe’s largest commercial tissue biobank. BIOMEX offers over 3,000,000 human tissue samples, primarily in FFPE block format, providing an unrivaled resource for oncology research and diagnostics. Highlights: Comprehensive Collection: Expanding through partnerships with pathologists, our biobank includes essential data on cancer type, organ, morphology, tumor size, […]
20 YEARS BIOMEX
On July 1st, we celebrate a significant milestone: 20 years of BIOMEX under the responsibility of Mr. Bosnjak. From its humble beginnings as a supplier of biological materials, BIOMEX has grown to become Europe’s leading supplier of human biological samples and a pioneering manufacturer in diagnostics and life sciences, thanks to its dedicated team and […]
BIOMEX at ISSCR 2024
We look back on our incredible experience at ISSCR 2024 in Hamburg! It was truly a great experience to be part of such a lively event alongside other companies in stem cell research. Our BIOMEX team had a fantastic time at the conference, engaging in stimulating discussions and making valuable contacts around our latest innovation, […]
Exciting Announcement from BIOMEX: Advancing Neurological Research!
We’re thrilled to announce our latest initiative aimed at propelling neurological research forward. At BIOMEX, we recognize the critical need for diverse and readily available biospecimen, especially in fields like Multiple Sclerosis (MS) and Alzheimer’s Disease (AD). That’s why we’ve proactively established a robust network of physicians and neurologists dedicated to sourcing fresh biospecimens to […]
Empowering early detection with our cardiac biomarkers
According to the WHO, cardiovascular diseases are still the most common cause of death worldwide. In Germany alone, over 20% of women and more than 25% of men aged 65 and above suffer from coronary heart disease, a precursor to potentially fatal heart attacks. Patients with heart failure deserve similar attention, as their average five-year […]
Another successful “Get Together” hosted by Mex Group!
Together with our colleagues from ESfEQA, DiaMex, provitro and Symbiosis it was time for our second „Get Together” organized by our holding Mex Group. It was a pleasure to meet our colleagues, share our thoughts and experiences and strengthen our collaboration. Among other things, we had the opportunity to present our new, innovative project to […]
BIOMEX at CACLP 2024 in China
From March 16 to 18, BIOMEX attended CACLP 2024 with its own booth, N3-0828. The highlight was our special session, during which our colleagues Ling Cheng, Lu Li, and our general manager, Oliver Bosnjak, provided valuable insights into the supply of human biological specimens to China, the regulatory challenges and solutions, as well as our […]
